University of Vermont

College of Medicine

Department of Medicine

Pulmonary Disease & Critical Care Medicine

Bio for Anne Dixon, M.A., B.M., B.Ch.
Anne Dixon, M.A., B.M., B.Ch.

Anne Dixon, M.A., B.M., B.Ch.

Professor and Director, Pulmonary and Critical Care Medicine
Department of Medicine


Contact Information
E-mail: Anne.Dixon@uvm.edu
Office Location:
89 Beaumont Avenue, Given Bldg D209, Burlington, VT 05405

Education

1990 Graduate: Oxford University, England B.M., B.Ch.
1987 Undergraduate: Cambridge University, England, B.A. in Natural Sciences (M.A., 1990)
Residency: Johns Hopkins, Baltimore, Maryland
Fellowship: University of Washington, Seattle, Washington

Research Interests

Dr. Dixon’s research interest has focused on understanding the effects of obesity and metabolism on lung disease. She had developed a research program at UVM focused on this area. She was the lead editor of the first book published on obesity and lung disease, and the lead author of an ATS statement on obesity and asthma. She has organized four international meetings with Dr. Ben Suratt bringing together experts in the field of lung disease with experts in the field of obesity and metabolism, her overall goal for these meetings is to advance this field, and foster the career development of new researchers in the emerging field of obesity and lung disease.

Her group has pioneered the concept of different phenotypes of asthma and obesity. Recently, Dr. Dixon and Dr. Jason Bates were awarded an RO1 to study the pathophysiology and treatment of late-onset non-allergic asthma of obesity. Also in 2016, Dr. Dixon and Dr. Matthew Poynter were awarded an RO1 to study the effect of obesity on allergic airway disease. The ultimate goal of this research is to develop novel treatments for this patient population, a patient population that now represents the majority of patients with severe asthma, and a group that does not respond as well to traditional asthma therapies.

More information on clinical trials at UVM can be found here:
http://www.med.uvm.edu/vermontlung/clinical_trials

More information on obesity research at UVM can be found here:
http://www.uvm.edu/medicine/obesity/

Publications

Dixon AE, Castro M, Cohen RI, Gerald LB, Holbrook JT, Irvin CG, Mohapatra S, Peters SP, Rayapudi S, Sugar EA, Wise RA. Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma. J Allergy Clin Immunol. 2015 Mar, 135(3): 701-709
Dixon AE, Subramanian M, DeSarno M, Black K, Holguin F. A pilot randomized controlled trial of pioglitazone for the treatment of poorly controlled asthma in obesity.  Respir 2015 Nov, 26; 16, 143
Dixon AE & ME Poynter. Mechanisms of Asthma in Obesity: pleiotropic aspects of obesity produce distinct asthma phenotypes. Am J Respir Cell Mol Biol, 2016 May; 54(5); 601-8
Dixon AE & M Rincon. Metabolic dysfunction: mediator of the link between obesity and asthma? Lancet Respir Medicine 2016 July, 4(7); 533-4
Additional publications at PubMed:
http://www.ncbi.nlm.nih.gov/pubmed/?term=Dixon+AE